The battle to save accident victims in Intensive Care often extends beyond treating the original injury, with multiple organ failure (MOF) presenting a constant threat.
Author: Marlin Admin
Study develops clearer picture for bowel cancer risk
Patients with a high hereditary risk of developing colorectal cancer will benefit from a new international study involving Hunter Medical Research Institute geneticist Professor Rodney Scott which refines the global database of genetic information.
Push for children to have a ball during the holidays
With the NSW Christmas school holidays in full swing, HMRI researcher Associate Professor David Lubans is urging children to spend more time in the backyard and less in front of the television and computer.
The benefits of thinking on your feet in the workplace
University of Newcastle physical activity researcher Professor Ron Plotnikoff is taking a stand against sedentary office work, describing sitting as the new “smoking” in terms of Australia’s public health risk.
Protein targeted as potential melanoma treatment
A new protein that mediates the survival and death of melanoma cells has been identified by University of Newcastle cancer researchers, bringing hope for a new treatment method for the disease.
No ifs no butts – smoking research to reform apartment laws
As a medical researcher it’s a great feeling to see the NSW Government responding to our study of second-hand smoke (SHS) exposure in multi-unit dwellings, with bans on smoking in building common areas set to be enacted this year.
Expectant mums missing the alcohol message
In an alcohol study that we’ve just had published in the international journal PLOS One, we found that over 50 per cent of women with a history of binge drinking will continue the pattern during pregnancy, while fewer than 20 per cent choose to abstain.
Hunter-based cancer therapy secures $27.1m funding
Viralytics Limited, a biotech company with formative links to the Hunter Medical Research Institute, has announced a capital raising venture of $27.1 million which is set to fund the completion of international clinical trials for a targeted anti-cancer therapy known as CAVATAK™.
New equipment making labour studies less laborious
Uterine Contraction Bioassay is one of the fundamental laboratory techniques used within the Centre to study contractile forces.
Stroke trial lures imaging expert back to Hunter
The Hunter’s renowned stroke research group is to be bolstered by the return of award-winning imaging expert Dr Andrew Bivard to work on acute care and rehabilitation projects.
